Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death
- PMID: 9438340
- DOI: 10.1002/(SICI)1520-6408(1997)21:4<258::AID-DVG3>3.0.CO;2-6
Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death
Abstract
We have investigated the role of cyclin-dependent kinases in cell death and found that the expression of cyclin-dependent kinase 5 (Cdk5) is associated with apoptotic cell death in both adult and embryonic tissues. By double labeling immunohistochemistry and confocal microscopy, we specifically associated the expression of Cdk5 to dying cells. The association of Cdks with cell death is unique to Cdk5 as this association is not found with the other Cdks (Cdk 1-8) and cell death. The differential increase in Cdk5 expression is at the level of protein only, and no differences can be detected at the level of mRNA Using both limbs of mutant mice detective in the pattern of interdigital cell death and limbs with increased interdigital cell death by retinoic acid treatment, we confirmed the specificity of Cdk5 protein expression in dying cells. To investigate the regulation of Cdk5 during cell death, we examined the expression of a regulatory protein of Cdk5, p35, and found p35 to be expressed in the dying cells as well. Similar to Cdk5, there is also no specific differential expression of the p35 mRNA in dying cells. Our results suggest a role for Cdk5 and p35 proteins in cell death. This protein complex may function in the rearrangement of the cytoskeleton during apoptosis.
Similar articles
-
Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3.EMBO J. 2002 Feb 1;21(3):324-33. doi: 10.1093/emboj/21.3.324. EMBO J. 2002. PMID: 11823425 Free PMC article.
-
Cyclin dependent kinase 5 and its interacting proteins in cell death induced in vivo by cyclophosphamide in developing mouse embryos.Cell Death Differ. 2002 Apr;9(4):421-30. doi: 10.1038/sj.cdd.4400967. Cell Death Differ. 2002. PMID: 11965495
-
p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.J Biol Chem. 1998 Sep 11;273(37):24057-64. doi: 10.1074/jbc.273.37.24057. J Biol Chem. 1998. PMID: 9727024
-
Protein-protein interactions in Cdk5 regulation and function.Neurosignals. 2003 Sep-Oct;12(4-5):230-8. doi: 10.1159/000074625. Neurosignals. 2003. PMID: 14673210 Review.
-
Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.Mol Neurobiol. 2006 Aug;34(1):27-50. doi: 10.1385/mn:34:1:27. Mol Neurobiol. 2006. PMID: 17003520 Review.
Cited by
-
Down-regulation of cyclin-dependent kinase 5 attenuates p53-dependent apoptosis of hippocampal CA1 pyramidal neurons following transient cerebral ischemia.Sci Rep. 2019 Sep 10;9(1):13032. doi: 10.1038/s41598-019-49623-x. Sci Rep. 2019. PMID: 31506563 Free PMC article.
-
No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro.Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2884-9. doi: 10.1073/pnas.0912718107. Epub 2010 Feb 1. Proc Natl Acad Sci U S A. 2010. PMID: 20133653 Free PMC article.
-
Regulation of Sox6 by cyclin dependent kinase 5 in brain.PLoS One. 2014 Mar 24;9(3):e89310. doi: 10.1371/journal.pone.0089310. eCollection 2014. PLoS One. 2014. PMID: 24662752 Free PMC article.
-
Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo.Mol Cell Biol. 1999 Jan;19(1):353-63. doi: 10.1128/MCB.19.1.353. Mol Cell Biol. 1999. PMID: 9858559 Free PMC article.
-
Intracellular signalling pathways in dopamine cell death and axonal degeneration.Prog Brain Res. 2010;183:79-97. doi: 10.1016/S0079-6123(10)83005-5. Prog Brain Res. 2010. PMID: 20696316 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials